Literature DB >> 206304

Action of guanethidine on rabbit atrial membranes.

Y Misu, H Nishio.   

Abstract

1 Intracellular potentials were recorded in driven left atria from reserpine-treated rabbits. Guanethidine 2 X 10(-5) M slightly increased Vmax and shortened the total duration (TD) of the action potential (AP) without causing hyperpolarization. For the first 30 min after 4 X 10(-4) M, Vmax increased without hyperpolarization and AP height increased slightly. Thereafter, Vmax and height decreased with a slight and gradual depolarization. This depolarization was irreversible. TD was increased after 15 minutes. Guanethidine 2 X 10(-3) M initially decreased Vmax and height before causing depolarization. 2. Pretreatment with tetrodotoxin (TTX) 1.6 X 10(-7) M prevented or reversed the initial increases in Vmax, height and TD induced by guanethidine (4 X 10(-4) M). 3 TTX 3.1 to 6.2 X 10(-6) M, added 15 or 30 min after guanethidine 4 X 10(-4) M, delayed or prevented depolarization by guanethidine. 4 Ouabain 10(-5) M incubated for 20 and 90 min greatly inhibited Na+, K+-adenosine triphosphatase and K+-phosphatase activities; guanethidine was without effect. 5 Guanethidine probably increases resting sodium permeability after the promotion of increases in sodium permeability during the AP. High doses of the drug decrease sodium permeability during the AP.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 206304      PMCID: PMC1668281          DOI: 10.1111/j.1476-5381.1978.tb07769.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  GUANETHIDINE AS AN ANTI-FIBRILLATORY AGENT.

Authors:  P E LEVEQUE
Journal:  Nature       Date:  1964-09-26       Impact factor: 49.962

2.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

Review 3.  ADRENERGIC NEURONE BLOCKING AGENTS.

Authors:  A L BOURA; A F GREEN
Journal:  Annu Rev Pharmacol       Date:  1965       Impact factor: 13.820

4.  PHYSIOLOGICAL DISPOSITION OF GUANETHIDINE IN THE RAT AND ITS UPTAKE BY HEART SLICES.

Authors:  L S SCHANKER; A S MORRISON
Journal:  Int J Neuropharmacol       Date:  1965-02

5.  The effect of the cardiac membrane potential on the rapid availability of the sodium-carrying system.

Authors:  S WEIDMANN
Journal:  J Physiol       Date:  1955-01-28       Impact factor: 5.182

6.  A quantitative description of membrane current and its application to conduction and excitation in nerve.

Authors:  A L HODGKIN; A F HUXLEY
Journal:  J Physiol       Date:  1952-08       Impact factor: 5.182

7.  On the mechanism of action of guanethidine and bretylium.

Authors:  B B Brodie; C C Chang; E Costa
Journal:  Br J Pharmacol Chemother       Date:  1965-08

8.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

9.  Extra-vesicular binding of noradrenaline and guanethidine in the adrenergic neurones of the rat heart: a proposed site of action of adrenergic neurone blocking agents.

Authors:  A Giachetti; R A Hollenbeck
Journal:  Br J Pharmacol       Date:  1976-12       Impact factor: 8.739

10.  A new guanidine derivative: dissociation of the adrenergic neuron blocking activity from local anesthetic activity.

Authors:  Y Misu; H Nishio; T Hosotani; S Hamano
Journal:  Jpn J Pharmacol       Date:  1976-06
View more
  3 in total

1.  Prevention by guanethidine analogues of output of noradrenaline induced by sodium reduction in rabbit ventricular slices.

Authors:  T Hosotani; Y Misu
Journal:  Br J Pharmacol       Date:  1978-09       Impact factor: 8.739

2.  Comparative studies of (--)-, (+/-)-propranolol, atenolol, guanethidine, bretylium and tetracaine on adrenergic transmission.

Authors:  M Kaiho; T Kubo; Y Misu
Journal:  Br J Pharmacol       Date:  1981-10       Impact factor: 8.739

3.  Further evidence for the prevention by guanethidine of noradrenaline efflux from rabbit ventricular slices induced by a low external sodium concentration.

Authors:  T Hosotani; Y Misu
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.